Drug-related research activities
Drug-related research
Drug-related research is crucial to understanding Europe’s drug problems. It enables Europe to learn lessons from the past, to sharpen the awareness and monitoring of the present and to prepare for the future, by looking at issues such as resource allocation, best practices, and the piloting of innovative approaches. On these web pages — specifically developed for researchers and professionals — you will find information on drug-related research resources in Member States, in the European Union and at the EMCDDA.
Calls and news
- The Horizon 2020 programme extended the submission deadline until 04/06/2020 to fund projects about: ‘Use of real world data to advance research on the management of complex chronic conditions’
- The Horizon 2020 programme extended the submission deadline until 04/06/2020 to fund projects: ‘Sustained collaboration of national and regional programmes in research on brain-related diseases and disorders of the nervous system’
- Horizon 2020 calls (all calls)
- COST open call on scientific and technical collaboration in Europe
External links
- Funding drug policy initiatives (DG Migration and Home Affairs)
- Horizon 2020 (DG Research and Innovation)
- NIDA's international program: fellowships and research grants
EMCDDA resources
- Links to EC-funded (Horizon 2020, FP7 and FP6) drug-related research projects
- Drug-related evidence: what works and what does not
- Drug research peer-reviewed journals in Europe
- Instruments for evaluating drug-related interventions
- Latest European Drug Report
- Access and download drug-related data
- EMCDDA 2012 thematic paper: 'Drug-related research in Europe: recent developments and future perspectives'
- National drug-related research (online information by country)
- EMCDDA scientific award

Belgium
Bulgaria




























